The demand in Next Generation Sequencing (NGS) technology shows no signs of slowing down as market research firm BCC Research predicts that the clinical NGS market will increase to more than $10.5 Billion by 2022
Rodin Therapeutics, a venture-backed biotechnology company that develops therapeutics for neurological disorders has announced that it uses Qlucore Omics Explorer to characterise its compounds response to treatment.
Illumina has announced an expanded partnership with Integrated DNA Technologies (IDT) to develop solutions for next-generation sequencing (NGS) library preparation multiplexing and a co-marketing agreement that links Illumina library prep with the IDT Exome Enrichment
Certara has announced that it is partnering with Phase I Unit, Peking Union Medical College (PUMC) Hospital’s Clinical Pharmacology Research Center (PUMCH-CPRC) in Beijing to help Chinese pharmaceutical companies enhance their drug development processes
SolveBio and Elsevier have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated pathways
Market research firm Technavio has prepared a report forecasting the global LIMS market growth from the period of 2017-2021. In the report Technavio’s analysts forecast the global LIMS market to grow at a CAGR of 8.94 per cent during the period 2017-2021
Optibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibrium’s StarDrop software
Oxford Gene Technology has expanded its SureSeq myPanel NGS Custom Cancer Panel content. The expansion comes in response to increasing use of NGS as a tool for research into an increasing number of cancer types allowing researchers to obtain reliable data for difficult-to-sequence genes and mutations.
Autoscribe Informatics has announced that it has strengthened its technical marketing and support team on both sides of the Atlantic.
Robert Roe discovers that the future of drug development will increasingly rely on advanced software tools that can not only produce and manage data but also help scientists to make better decisions
Image credit: B-th/Shutterstock.com
A round-up of the latest cooling technologies for scientists using HPC to support their research.
Credit: chayanuphol/Shutterstock
With the proliferation of artificial intelligence (AI) and machine learning (ML), the high-performance computing industry’s increasing workloads are contributing to environmental damage
Credit: Zapp2Photo/Shutterstock
Autonomous vehicles could help to prevent road accidents and save billions in damages across the world each year.
Credit: dotshock/Shutterstock
The pursuit of exascale HPC systems has been a target of the HPC community since the first petaflop system broke into the Top500 in the June 2008 edition of the biannual list of the fastest supercomputers based on the Linpack
Credit: Comsol
Simulation software is helping accelerate battery development, writes Gemma Church
Credit: Omelchenko shutterstock
Developing skills to use advanced computing resources such as high-performance computing (HPC), artificial intelligence (AI) and machine learning (ML), and quantum computing is becoming an increasingly important skill set for
